Bioequivalence Study in Healthy Volunteers for Empagliflozin/Metformin Fixed Dose Combination Compared to Separate Tablets

NCT02028767 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Empagliflozin 2.5 mg
DRUG: Empagliflozin 10 mg
DRUG: Metformin 500 mg
DRUG: Empagliflozin/Metformin FDC

Sponsor

Boehringer Ingelheim